Sipro Pharma Limited - Company Profile

It is a chemicals public limited company based in Andhra Pradesh, Andhra Pradesh, India, established in 2004.
2004 Andhra Pradesh, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Sipro Pharma Limited

Sipro Pharma Limited, a struck off public limited company, was established on 25 October 2004 in Andhra Pradesh, Andhra Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239AP2004PLC044487. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Venkata Ramana Velaga (Director), Raja Rao Nannamuri (Director), Venkata Ramana Kumari Karusala (Managing Director). Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 30 September 2013. It is based at Flatno. 102. 3 Block Kalyanrbr Complex Miyapur. Hyderabad, Andhra Pradesh, Andhra Pradesh, 500049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239AP2004PLC044487

  • Registration Number

    044487

  • Incorporation Date

    25 October 2004

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 30 Sep 2013
Company report

Sipro Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sipro Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sipro Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Ramana Velaga Director 18 Dec 2004 Current
Raja Rao Nannamuri Director 01 Jan 2005 Current
Venkata Ramana Kumari Karusala Managing Director 25 Oct 2004 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sipro Pharma.

Enhance accessibility to Sipro Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sipro Pharma revenue growth over time
Sipro Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sipro Pharma?

Unlock access to Sipro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sipro Pharma?

Unlock and access historical data on people associated with Sipro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sipro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sipro Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sipro Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sipro Pharma Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Sipro Pharma Limited has filed its annual Financial statements for the year ended 30 Sep 2013 with Roc Vijayawada. was recorded as a recent event.

  • Director Appointment

    Raja Rao Nannamuri was appointed as a Director was appointed as a Director on 01 Jan 2005 & has been associated with this company since 21 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Venkata Ramana Velaga was appointed as a Director was appointed as a Director on 18 Dec 2004 & has been associated with this company since 21 years 2 months . was completed.

  • Director Appointment

    Venkata Ramana Kumari Karusala was appointed as a Managing Director was appointed as a Managing Director on 25 Oct 2004 & has been associated with this company since 21 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Sipro Pharma Limited was registered on 25 Oct 2004 with Roc Vijayawada & aged 21 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sipro Pharma Limited?

The CIN of Sipro Pharma Limited is U24239AP2004PLC044487.

Where is Sipro Pharma Limited headquartered?

Sipro Pharma Limited is headquartered at Flatno. 102. 3 Block Kalyanrbr Complex Miyapur. Hyderabad, Andhra Pradesh, Andhra Pradesh, 500049.

When was Sipro Pharma Limited incorporated?

Sipro Pharma Limited was incorporated on 25 October 2004.

Who are the current directors of Sipro Pharma Limited?

The current directors of Sipro Pharma Limited are

What is the primary industry of Sipro Pharma Limited?

The primary industry of Sipro Pharma Limited is Chemicals.

Is Sipro Pharma Limited a listed company?

Sipro Pharma Limited is unlisted.

What is the capital structure of Sipro Pharma Limited?

The authorized capital of Sipro Pharma Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available